Centene Corp reported results for the second quarter of 2026, posting revenue of $53.6B and net income attributable to Centene of $1.09B, or diluted EPS of $2.19, versus revenue of $48.7B and a net loss of $250M (loss per share $0.51) in the year-earlier quarter.
Financial Highlights
- Revenue: $53.6B for Q2 2026, up from $48.7B in Q2 2025 (10% YoY).
- Net income: $1.09B attributable to Centene for Q2 2026, vs. $(0.25)B in Q2 2025 (turnaround to profit).
- Diluted EPS: $2.19 for Q2 2026, vs. $(0.51) in Q2 2025.
Business Highlights
- Total revenues rose 10% year over year, driven by higher premium tax, growth in PDP premiums and membership, and rate increases across Medicaid and Marketplace.
- Managed care membership declined 8% year over year, reflecting lower Medicaid and Marketplace membership following public health emergency redeterminations.
- Medicare/PDP momentum strengthened with higher PDP membership and premiums, improving Medicare gross margin and reducing SG&A as a percentage of revenue.
- Operational progress included multiple state contract wins and renewals (Nevada, California dental, Iowa, Mississippi) and D‑SNP integration efforts positioning the company for 2027–2030.
- Care and cost management measures improved HBR to about 89.6% through pricing actions, clinical initiatives, network design and fraud/waste controls.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.